Debate-guidelines for GRE control-the case for optimism.
Although at first sight the spread of glycopeptide-resistant enterococci (GREs) appears to be following the same unrelenting path as that of methicillin-resistant Staphylococcus aureus, closer inspection of the Literature indicates success of certain interventions, particularly the control of antibiotic usage. There are grounds for optimism that assiduous application of antibiotic control and other infection control measures may further reduce the prevalence of GREs.
Barrett
S P
SP
Department of Microbiology, Charing Cross Hospital, London, UK. s.barrett@imperial.ac.uk
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D004352:Drug Resistance, Microbial; D004363:Drug Utilization / Q000592:standards; D019353:Endemic Diseases / Q000517:prevention & control / Q000706:statistics & numerical data; D016983:Enterococcus; D019317:Evidence-Based Medicine; D014943:Global Health; D006020:Glycopeptides; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D006801:Humans; D006920:Hygiene / Q000592:standards; D017053:Infection Control / Q000379:methods / Q000592:standards*; D016106:Methicillin Resistance; D017063:Outcome Assessment, Health Care; D011159:Population Surveillance; D017410:Practice Guidelines as Topic / Q000592:standards*; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control; D013211:Staphylococcus aureus
D000900:Anti-Bacterial Agents; D006020:Glycopeptides